Ipswich Investment Management Co., Inc. Dexcom Inc Transaction History

Ipswich Investment Management Co., Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 19, 2024	BUY	$114.22 - $140.1 $174,071 - $213,512	1,524 New	1,524 $211,000
Q2 2022 Jul 26, 2022	SELL	$67.99 - $132.89 $26,652 - $52,092	-392 Closed	0 $0
Q4 2021 Jan 24, 2022	BUY	$129.87 - $162.82 $1,948 - $2,442	15 Added 3.98%	392 $210,000
Q3 2021 Oct 07, 2021	BUY	$106.71 - $143.18 $40,229 - $53,978	377 New	377 $206,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Ipswich Investment Management Co., Inc., based on Form 13F filings with the SEC.

Stay updated on Ipswich Investment Management Co., Inc. with notifications on news.